Skip to main content
. 2013 Mar 6;34(22):1670–1680. doi: 10.1093/eurheartj/eht049

Figure 5.

Figure 5

Association of effects of adding an oral anticoagulant to single (aspirin) or dual (aspirin and clopidogrel) antiplatelet therapy on rate of MACE with effects on rate of clinically significant bleeding events after an acute coronary syndrome. Random-effects meta-regression, stratified on number of antiplatelet drugs. The area of a circle representing a study arm is proportional to its weight in the random-effects model. Shaded areas are 95% confidence intervals. HR, hazard ratio; MACE, major adverse cardiovascular events; Riv, rivaroxaban; Dab, dabigatran, Api, apixaban; Dar, darexaban; Xim, ximelagatran; b.i.d., twice daily; o.d., once daily; number denotes strength in milligram.